Studien

PROCAPP A randomized, open-label phase III trial of mapisal versus urea hand-foot cream as prophylaxis for capecitabine-induced hand-foot syndrome in patients with gastrointestinal tumors or breast cancer AIO-LQ-0111 · Studie beendet Studie anzeigen

NEOBRAF Neoadjuvant encorafenib, binimetinib and cetuximab for patients with BRAF mutated/pMMR localized colorectal cancer - AIO Phase II trial AIO-KRK-0420 · Studie beendet Studie anzeigen

NEOBIL Neoadjuvant bintrafusp alfa in patients with resectable biliary tract cancer AIO-HEP-0120 · Rekrutierung beendet Studie anzeigen

Re-Check Randomized phase II, open-label efficacy and safety study of second-line durvalumab plus tremelimumab versus platinum-based chemotherapy alone in patients with NSCLC and first-line checkpoint-inhibitor therapy followed by 2 cycles of platinum-based chemotherapy AIO-TRK-0221 · Studie beendet Studie anzeigen

ANTONIO Perioperative/Adjuvant atezolizumab in patients with MSIhigh or MMR-deficient stage III colorectal cancer ineligible for oxaliplatin-based chemotherapy – a Phase II study AIO-KRK-0220 · Rekrutierung beendet Studie anzeigen

MEFOX A phase I/II trial of D,L-MEthadone and mFOLFOX6 in treatment of advanced colorectal cancer AIO-KRK-0119 · In Rekrutierung Studie anzeigen

AIO-SUP-0121 Quality Assurance on Anemia Management in Patients with Solid Tumors and Malignant Lymphoma - finished AIO-SUP-0121 · Rekrutierung beendet Studie anzeigen

GOBLET A phase 1 / 2 multiple-indication biomarker, safety, and efficacy study in advanced or metastatic Gastrointestinal cancers explOring treatment comBinations with peLarEorep and aTezolizumab AIO-KRK-PAK-0320/ass · In Rekrutierung Studie anzeigen

ATOMIC Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair AIO-KRK-0317 · Rekrutierung beendet Studie anzeigen

ROSE Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study AIO-YMO/TRK-0120 · Rekrutierung beendet Studie anzeigen